Literature DB >> 35979968

Overexpressed angiotensin-converting enzyme in neutrophils suppresses glomerular damage in crescentic glomerulonephritis.

Suguru Saito1, Narihito Tatsumoto2, Duo-Yao Cao1, Nobuyuki Nosaka3, Hiroshi Nishi4, Daniel N Leal2, Ellen Bernstein1, Kenichi Shimada3,5, Moshe Arditi3,5, Kenneth E Bernstein2,1, Michifumi Yamashita2.   

Abstract

While angiotensin-converting enzyme (ACE) regulates blood pressure by producing angiotensin II as part of the renin-angiotensin system, we recently reported that elevated ACE in neutrophils promotes an effective immune response and increases resistance to infection. Here, we investigate if such neutrophils protect against renal injury in immune complex (IC)-mediated crescentic glomerulonephritis (GN) through complement. Nephrotoxic serum nephritis (NTN) was induced in wild-type and NeuACE mice that overexpress ACE in neutrophils. Glomerular injury of NTN in NeuACE mice was attenuated with much less proteinuria, milder histological injury, and reduced IC deposits, but presented with more glomerular neutrophils in the early stage of the disease. There were no significant defects in T and B cell functions in NeuACE mice. NeuACE neutrophils exhibited enhanced IC uptake with elevated surface expression of FcγRII/III and complement receptor CR1/2. IC uptake in neutrophils was enhanced by NeuACE serum containing elevated complement C3b. Given no significant complement activation by ACE, this suggests that neutrophil ACE indirectly preactivates C3 and that the C3b-CR1/2 axis and elevated FcγRII/III play a central role in IC elimination by neutrophils, resulting in reduced glomerular injury. The present study identified a novel renoprotective role of ACE in glomerulonephritis; elevated neutrophilic ACE promotes elimination of locally formed ICs in glomeruli via C3b-CR1/2 and FcγRII/III, ameliorating glomerular injury.NEW & NOTEWORTHY We studied immune complex (IC)-mediated crescentic glomerulonephritis in NeuACE mice that overexpress ACE only in neutrophils. Such mice show no significant defects in humoral immunity but strongly resist nephrotoxic serum nephritis (less proteinuria, milder histological damage, reduced IC deposits, and more glomerular neutrophils). NeuACE neutrophils enhanced IC uptake via increased surface expression of CR1/2 and FcgRII/III, as well as elevated serum complement C3b. These results suggest neutrophil ACE as a novel approach to reducing glomerulonephritis.

Entities:  

Keywords:  C3; angiotensin-converting enzyme; complement; crescentic glomerulonephritis; immune complex; neutrophil

Mesh:

Substances:

Year:  2022        PMID: 35979968      PMCID: PMC9484997          DOI: 10.1152/ajprenal.00067.2022

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  53 in total

1.  Toward quantitating the burden of glomerulonephritis in the United States.

Authors:  Daniel C Cattran
Journal:  Kidney Int       Date:  2016-10       Impact factor: 10.612

2.  Conditional ablation of macrophages halts progression of crescentic glomerulonephritis.

Authors:  Jeremy S Duffield; Peter G Tipping; Tiina Kipari; Jean-François Cailhier; Spike Clay; Richard Lang; Joseph V Bonventre; Jeremy Hughes
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

3.  Experimental glomerulonephritis.

Authors:  D J Salant; A V Cybulsky
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  Transfusion of CD206+ M2 Macrophages Ameliorates Antibody-Mediated Glomerulonephritis in Mice.

Authors:  Qiuna Du; Naotake Tsuboi; Yiqin Shi; Sachiko Ito; Yutaka Sugiyama; Kazuhiro Furuhashi; Nobuhide Endo; Hangsoo Kim; Takayuki Katsuno; Shin'ichi Akiyama; Seiichi Matsuo; Ken-Ichi Isobe; Shoichi Maruyama
Journal:  Am J Pathol       Date:  2016-11-14       Impact factor: 4.307

5.  Ramipril: review of pharmacology.

Authors:  R A Becker; B Schölkens
Journal:  Am J Cardiol       Date:  1987-04-24       Impact factor: 2.778

6.  Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.

Authors:  Kenneth E Bernstein; Yosef Koronyo; Brenda C Salumbides; Julia Sheyn; Lindsey Pelissier; Dahabada H J Lopes; Kandarp H Shah; Ellen A Bernstein; Dieu-Trang Fuchs; Jeff J-Y Yu; Michael Pham; Keith L Black; Xiao Z Shen; Sebastien Fuchs; Maya Koronyo-Hamaoui
Journal:  J Clin Invest       Date:  2014-03       Impact factor: 14.808

7.  Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase.

Authors:  G Schrijver; M J Bogman; K J Assmann; R M de Waal; H C Robben; H van Gasteren; R A Koene
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

8.  In vitro Demonstration and Quantification of Neutrophil Extracellular Trap Formation.

Authors:  Dongsheng Jiang; Mona Saffarzadeh; Karin Scharffetter-Kochanek
Journal:  Bio Protoc       Date:  2017-07-05

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3β Reinforces the Nrf2 Antioxidant Defense against Podocytopathy.

Authors:  Sijie Zhou; Pei Wang; Yingjin Qiao; Yan Ge; Yingzi Wang; Songxia Quan; Ricky Yao; Shougang Zhuang; Li Juan Wang; Yong Du; Zhangsuo Liu; Rujun Gong
Journal:  J Am Soc Nephrol       Date:  2015-12-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.